Rafal Dziadziuszko

8PUBLICATIONS
72CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 13, 2026
Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.

Glenwood D Goss, Gail E Darling, Virginie Westeel

|Jan 09, 2026
TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden-High Tumors.

David M Thomas, Jeong Eun Kim, Fabrice Barlesi

|Jul 09, 2025
Single-Agent Divarasib in Patients With KRAS G12C-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.

Adrian G Sacher, Wilson H Miller, Manish R Patel

|Jul 23, 2024
At the Crossroads of Local and Systemic Treatment of Operable Non-Small Cell Lung Cancer.

Rafal Dziadziuszko, Witold Rzyman

|May 24, 2024
Moving Immunotherapy Into the Treatment of Resectable Non-Small Cell Lung Cancer.

Jamie E Chaft, Rafal Dziadziuszko, Bernardo Haddock Lobo Goulart

Pageof 2